G2 Therapies

G2 Therapies aims to develop therapeutic monoclonal antibody treatments. The company's technology focuses on the development and commercialization of antibody-based therapeutics in inflammation and other fields, enabling users to generate antibodies that outperform chemokine receptor targets, which have proven difficult to inhibit using conventional methods.